Hemorrhagic stroke management: Difference between revisions
(Created page with "__NOTOC__ {{Hemorrhagic stroke}} {{CMG}} ==Overview== ==Medical therapy== ==References== {{reflist|2}} Category:Neurology Category:Cardiology Category:Neuros...") |
No edit summary |
||
Line 7: | Line 7: | ||
==Medical therapy== | ==Medical therapy== | ||
[[Anticoagulant]]s and antithrombotics, key in treating ischemic stroke, can make bleeding worse and cannot be used in intracerebral hemorrhage. Patients are monitored and their blood pressure, blood sugar, and oxygenation are kept at optimum levels. | |||
Revision as of 15:20, 9 November 2016
Hemorrhagic stroke Microchapters |
Diagnosis |
---|
Treatment |
AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015) |
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012) |
AHA/ASA Guideline Recommendation for the Primary Prevention of Stroke (2014) |
AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (2014) Sex-Specific Risk Factors
Risk Factors Commoner in Women |
Case Studies |
Hemorrhagic stroke management On the Web |
American Roentgen Ray Society Images of Hemorrhagic stroke management |
Risk calculators and risk factors for Hemorrhagic stroke management |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical therapy
Anticoagulants and antithrombotics, key in treating ischemic stroke, can make bleeding worse and cannot be used in intracerebral hemorrhage. Patients are monitored and their blood pressure, blood sugar, and oxygenation are kept at optimum levels.